Neuralink unveils trial linking brain implant to robotic arm
In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control using the N1 implant to an investigational assistive robotic arm," adding that it is "an important first step towards restoring not only digital freedom, but also physical freedom."
Neuralink plans to enroll participants from its ongoing PRIME trial into this feasibility study, as mentioned in a post on ...
Neuralink, which company received Food and Drug Administration clearance in May 2023 to launch human trials, has so far only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback